Fulcrum Therapeutics, Inc. Common Stock (FULC) is a publicly traded Healthcare sector company. As of November 12, 2026, FULC trades at $3.79 with a market cap of $285.67M and a P/E ratio of -23.09. FULC moved -1.60% today. Year to date, FULC is -66.01%; over the trailing twelve months it is -55.92%. Its 52-week range spans $2.32 to $15.74. Analyst consensus is neutral with an average price target of $0.00. Rallies surfaces FULC's financials, insider trades, hedge fund holdings, congressional trades, analyst ratings, and AI-generated research below.
Rallies community data for FULC shows anonymized retail investor ownership, positioning, sentiment, and portfolio context when enough community data is available.
| Metric | Value |
|---|---|
| Price | $3.79 |
| Market Cap | $285.67M |
| P/E Ratio | -23.09 |
| EPS | $-0.16 |
| Dividend Yield | 0.00% |
| 52-Week High | $15.74 |
| 52-Week Low | $2.32 |
| Volume | 1.93M |
| Avg Volume | 0 |
| Revenue (TTM) | $80.00M |
| Net Income | $-9.72M |
| Gross Margin | 0.00% |
1 analysts cover FULC: 0 strong buy, 0 buy, 1 hold, 0 sell, 0 strong sell. Consensus rating is neutral. Average price target: $0.00.